Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.49 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.47 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.46 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.46 |
| ▸ | BID | P55957 | 3/20 | 0.44 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.44 |
| ▸ | PPARA | Q07869 | 3/20 | 0.44 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.44 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.44 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.44 |
| ▸ | PPARG | P37231 | 2/20 | 0.44 |
| ▸ | EP300 | Q09472 | 1/20 | 0.44 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.44 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.44 |
| ▸ | KAT5 | Q92993 | 1/20 | 0.44 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.44 |
| ▸ | THRA | P10827 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28243243 | 1.00 | GPR84 (0.49) | GPR84LIPGNR1H2NR1H3BID | |
| SCHEMBL10767574 | 1.00 | GPR84 (0.49) | GPR84LIPGNR1H2NR1H3BID | |
| SCHEMBL27397512 | 1.00 | GPR84 (0.49) | GPR84LIPGNR1H2NR1H3BID | |
| SCHEMBL10764266 | 1.00 | GPR84 (0.49) | GPR84LIPGNR1H2NR1H3BID | |
| SCHEMBL14974903 | 1.00 | GPR84 (0.49) | GPR84LIPGNR1H2NR1H3BID | |
| SCHEMBL2495417 | 0.98 | GPR84 (0.46) | GPR84LIPGNR1H2NR1H3BID | |
| SCHEMBL10692239 | 0.93 | DAO (0.41) | GPR84LIPGNR1H2NR1H3BID | |
| SCHEMBL9234355 | 0.91 | DAO (0.45) | GPR84LIPGNR1H2NR1H3BID | |
| SCHEMBL174911 | 0.85 | KDM4E (0.44) | GPR84MCL1THRBKDM4EALDH1A1 | |
| SCHEMBL28003330 | 0.83 | BID (0.44) | GPR84BIDMCL1PPARABCL2L1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1375610-B1 | Phase change inks containing dimeric azo pyridone colorants | XEROX CORP (US) | 2007-04-04 | — | — | EP | disclosed |
| EP-1375599-B1 | Dimeric azo pyridone colorants | XEROX CORP (US) | 2006-10-04 | — | — | EP | disclosed |
| CN-1702545-A | Method for forming temporary image | XEROX CORP (US) | 2005-11-30 | — | — | CN | disclosed |
| CN-1702546-A | Method for forming temporary image | XEROX CORP (US) | 2005-11-30 | — | — | CN | disclosed |
| US-6713614-B2 | PHASE CHANGE INKS | XEROX CORPORATION | 2004-03-30 | — | — | US | disclosed |
| US-6696552-B2 | AMIDATION BETWEEN PRIMARY AMINE AND ESTER HAVING ELECTRON WITHDRAWING FUNCTIONALITY; CYCLIZATION WITH KETO ESTER | XEROX CORPORATION | 2004-02-24 | — | — | US | disclosed |
| US-20040010058-A1 | DIMERIC AZO PYRIDONE COLORANTS | XEROX CORPORATION | 2004-01-15 | — | — | US | disclosed |
| US-20040006234-A1 | PROCESS FOR PREPARING SUBSTITUTED PYRIDONE COMPOUNDS | XEROX CORPORATION | 2004-01-08 | — | — | US | disclosed |
| EP-1375610-A1 | Phase change inks containing dimeric azo pyridone colorants | Xerox Corporation (US) | 2004-01-02 | — | — | EP | disclosed |
| EP-1375599-A1 | Dimeric azo pyridone colorants | Xerox Corporation (US) | 2004-01-02 | — | — | EP | disclosed |
| US-6663703-B1 | Nonsettling hot melt color materials and carriers comprising stearyl stearamide, the reaction product of dimer acid, ethylene diamine and stearic acid or mixtures, used in ink jets printers, having colorfastness, heat and photostability | XEROX CORPORATION | 2003-12-16 | — | — | US | disclosed |
| US-6576747-B1 | Reacting alkylenediol and isatoic anhydride in presence of 1,4-diazabicyclo(2.2.2)octane and/or N,N,N*,N*-tetramethylenediamine; heating, decyclization, salt formation | XEROX CORPORATION | 2003-06-10 | — | — | US | disclosed |
| US-6576748-B1 | Diazotizing dianiline compound; salt formation, coupling, desalting; reaction with pyridone or dipyridone compound | XEROX CORPORATION | 2003-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040006234-A1 | PROCESS FOR PREPARING SUBSTITUTED PYRIDONE COMPOUNDS | PDXK, DPYD, RRM2B | GPR84 4329/4885LIPG 4540/4885NR1H2 3109/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.